Novo Nordisk A/S <NVO.N> expected to post earnings of DKK6.02 a share - Earnings Preview
Novo Nordisk A/S NVO.N, NVO is expected to show a rise in quarterly revenue when it reports results on November 6 for the period ending September 30 2024
The Bagsvaerd Denmark-based company is expected to report a 21.9% increase in revenue to DKK71.579 billion from DKK58.73 billion a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for Novo Nordisk A/S is for earnings of DKK6.02 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts had risen by about 0.2% in the last three months.
Wall Street's median 12-month price target for Novo Nordisk A/S is 155.00, above its last closing price of $111.94.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2024 | 4.64 | 4.77 | 4.49 | Missed | -5.9 |
Jan. 1 2024 | 5.13 | 5.68 | Beat | 10.8 | |
Sep. 30 2023 | 4.47 | 4.47 | 4.91 | Beat | 9.9 |
Sep. 30 2023 | 4.94 | 5.01 | 5.00 | Missed | -0.3 |
Jan. 1 0001 | 4.45 | 4.35 | 4.32 | Missed | -0.7 |
Jan. 1 0001 | 4.29 | 4.33 | 4.39 | Beat | 1.3 |
Dec. 31 2022 | 3.01 | 2.91 | 3.01 | Beat | 3.5 |
Sep. 30 2022 | 3.16 | 3.16 | 3.17 | Beat | 0.4 |
This summary was machine generated November 4 at 15:36 GMT. All figures in Danish crowns unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
</body></html>
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
